Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 897.00
+9.00 (1.01%)
Sep 22, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 63.2 billion as of September 22, 2026. Its market cap has decreased by -71.18% in one year.
Market Cap
63.20B
Enterprise Value
115.33B
Revenue
46.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
897.00
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 63.20B, a decrease of -73.36%. That is a compound annual growth rate of -9.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 63.20B | -36.13% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 138.14B |
| Genexine | 135.98B |
| Vaxcell-Bio Therapeutics | 101.52B |
| MedPacto | 93.57B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 69.95B |
| ENCell | 65.85B |
| ORIENT BIO | 54.13B |